Beijing, China

Cuihua Liu

This inventor holds 1 USPTO granted patent. Top assignee: Abbvie Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cuihua Liu. Retrieved from https://idiyas.com/inventor/cuihua-liu-w5pnynmw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Cuihua Liu

Introduction

Cuihua Liu is a prominent inventor based in Beijing, China. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of kinase inhibitors. Her work is crucial in the ongoing fight against cancer, showcasing her dedication to advancing medical research.

Latest Patents

Cuihua Liu holds a patent for "Bicyclic carboxamide inhibitors of kinases." This patent includes compounds of formula (I) or pharmaceutical acceptable salts, where specific variables are defined in the description. The patent outlines compositions containing these compounds and their uses as inhibitors of kinases such as ALK, which are essential for treating cancer.

Career Highlights

Cuihua Liu is currently employed at AbbVie Inc., a global biopharmaceutical company known for its innovative research and development. Her role at AbbVie allows her to collaborate with other leading scientists and contribute to groundbreaking research in oncology.

Collaborations

Cuihua Liu has worked alongside notable colleagues, including Anil Vasudevan and Thomas Dale Penning. These collaborations have further enhanced her research capabilities and have led to significant advancements in the field.

Conclusion

Cuihua Liu's innovative work in developing kinase inhibitors exemplifies her commitment to improving cancer treatment. Her contributions to the pharmaceutical industry are invaluable, and her ongoing research continues to inspire future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…